Log In
BCIQ
Print this Print this
 

G207

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionModified herpes virus type 1(HSV-1)
Molecular Target Not applicable
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationBrain cancer
Indication DetailsTreat brain cancer; Treat malignant brain tumors; Treat malignant glioma; Treat newly diagnosed glioblastoma multiforme (GBM)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/19/2010

Undisclosed

0

0

Get a free BioCentury trial today